- Home
- / Amunix Pharmaceuticals
Amunix Pharmaceuticals
Amunix Pharmaceuticals Summary
Company Summary
- Overview
- Amunix Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology. It utilizes the PRO-XTEN technology platform to discover and develop T-cell engagers and cytokine therapies for patients with cancer.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2006
- HQ
- South San Francisco, CA, US | view all locations
- Website
- https://www.amunix.com/
- Cybersecurity rating
Table of Contents
Key People
Volker Schellenberger, Chief Technology Officer
Theresa Dewitt, Vice President of Clinical Operations
Fatema Legrand, Vice President, Global Project Head, Head of Clinical Science, Interim Head of Biology and Targets
LocationsView all
1 location detected
South San Francisco, CA HQ
United States
2 Tower Pl #1100